Welcome to our dedicated page for Model N news (Ticker: MODN), a resource for investors and traders seeking the latest updates and insights on Model N stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Model N's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Model N's position in the market.
Model N plans to announce its financial results for the second quarter of fiscal year 2022 on May 10, 2022, after market close. The company will host a conference call at 2:00 p.m. PT (5:00 p.m. ET) on the same day to discuss these results and its business outlook. A live webcast will be available on the investor relations page of Model N's website, with a replay accessible until May 24, 2022.
Model N, Inc. (NYSE: MODN) successfully wrapped up its 18th annual Rainmaker22 conference, attracting over 700 industry executives and experts. The event showcased the new Model N 3.0 solution portfolio and introduced Model N Ngage, enhancing user experience with tailored in-app guidance. The 2022 State of Revenue Report highlighted key industry trends, revealing that 73% of revenue management professionals prefer partners offering software and expert services. Model N's innovative approach pairs technology with expertise, addressing ongoing challenges in revenue management and compliance.
Model N, Inc. (NYSE: MODN) released its 2022 State of Revenue Report, highlighting significant challenges in revenue management due to supply chain disruptions (44%), AI integration (40%), and staffing issues (98%). Notably, 99% of executives acknowledged the need for enhanced technology capabilities to optimize revenue processes. Despite a decline in pandemic-related concerns (37%), regulatory compliance remains a top issue for 81% of life sciences executives. The report reflects ongoing demands for innovative revenue management solutions in challenging market conditions.
Model N, a leader in cloud revenue management solutions, will have CEO Jason Blessing and CFO John Ederer present at the JMP Securities Technology Conference on March 8, 2022, at 8:30 a.m. PT (11:30 a.m. ET). The event will be accessible via webcast on Model N's investor relations page. As a trusted provider for over 120 countries, Model N offers integrated solutions for life sciences and high tech companies, helping to minimize revenue leakage and enhance operational efficiency.
Model N (NYSE: MODN) reported a 21% year-over-year revenue growth for Q1 FY2022, totaling $51.5 million. The subscription revenue also increased 21% to $38.1 million. Despite strong performance, the GAAP net loss widened to $(6.3) million, compared to $(5.2) million in Q1 FY2021. Gross profit rose 13% to $28.9 million, but gross margin declined to 56%. The company provided guidance for Q2 FY2022 with expected total revenues between $51.0 million and $51.5 million.
Model N, Inc. (NYSE: MODN) announces the launch of its new State Price Transparency Management (SPTM) SaaS solution aimed at aiding pharmaceutical and biotech companies in meeting state price transparency mandates. The solution automates compliance processes, ensuring traceability and standardization. Key features include legislative and reporting templates, a scheduled reports calendar, and analytical tools for assessing price impacts. This initiative reflects Model N's commitment to support life sciences firms in adapting to evolving regulatory demands.
Model N, Inc. (NYSE: MODN) announced that Alex Azar, former U.S. Secretary of Health and Human Services, will keynote its Rainmaker22 conference from March 21-23, 2022. This annual event focuses on revenue management innovation in life sciences and high-tech industries. Azar will share insights from his healthcare experience, emphasizing lessons learned during the COVID-19 pandemic. Rainmaker22 aims to unite leaders to discuss how Model N's cloud solutions enhance business growth and minimize revenue leakage, featuring 44 sessions led by industry experts.
GE has appointed Scott Reese as the new CEO of GE Digital, effective February 22, 2022, succeeding Patrick Byrne. Reese, previously with Autodesk, brings extensive experience in product development and growth strategies. His leadership is expected to enhance GE Digital's role in the upcoming energy company spin-off planned for 2024. Scott Strazik, CEO of GE's global energy business, expressed confidence in Reese's capabilities to drive digital transformation and decarbonization initiatives.
Model N, Inc. (NYSE: MODN) will announce its financial results for Q1 fiscal year 2022 on February 8, 2022, after market close. The company will host a conference call at 2:00 p.m. PT (5:00 p.m. ET) to discuss these results and provide a business outlook. Investors can access the call by dialing specific numbers or through a live webcast available on the Model N investor relations page. Model N specializes in cloud revenue management solutions, serving life sciences and high-tech companies worldwide.
Model N, Inc. (NYSE: MODN) announced its participation in Baird's Virtual Bus Tour on December 16, 2021, at 9:00 AM PT (12:00 PM ET). The event will be accessible via a live and replay webcast on the Model N investor relations page. As a leader in cloud revenue management solutions, Model N helps life sciences and high-tech companies enhance growth while minimizing revenue leakage. Trusted by major firms like Johnson & Johnson and AstraZeneca, Model N provides integrated solutions that automate pricing and compliance for profitable business scaling.